These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32923117)

  • 1. IL-17 suppresses the therapeutic activity of cancer vaccines through the inhibition of CD8
    Dadaglio G; Fayolle C; Oberkampf M; Tang A; Rudilla F; Couillin I; Torheim EA; Rosenbaum P; Leclerc C
    Oncoimmunology; 2020 May; 9(1):1758606. PubMed ID: 32923117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal TLR9 signal converts tolerogenic CD4-8- DCs into immunogenic ones capable of stimulating antitumor immunity via activating CD4+ Th1/Th17 and NK cell responses.
    Zhang X; Munegowda MA; Yuan J; Wei Y; Xiang J
    J Leukoc Biol; 2010 Aug; 88(2):393-403. PubMed ID: 20466823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.
    Xia D; Zheng S; Zhang W; He L; Wang Q; Pan J; Zhang L; Wang J; Cao X
    J Mol Med (Berl); 2003 Sep; 81(9):585-96. PubMed ID: 12937899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbohydrate-based adjuvants activate tumor-specific Th1 and CD8
    Xu X; Jin Z; Liu Y; Gong H; Sun Q; Zhang W; Zhao L
    Cancer Lett; 2019 Jan; 440-441():94-105. PubMed ID: 30352261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICOSL-augmented adenoviral-based vaccination induces a bipolar Th17/Th1 T cell response against unglycosylated MUC1 antigen.
    Carrell RK; Stanton RA; Ethier SP; LaRue AC; Soloff AC
    Vaccine; 2018 Oct; 36(42):6262-6269. PubMed ID: 30219366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
    Bagri P; Anipindi VC; Nguyen PV; Vitali D; Stämpfli MR; Kaushic C
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12.
    Kaiga T; Sato M; Kaneda H; Iwakura Y; Takayama T; Tahara H
    J Immunol; 2007 Jun; 178(12):7571-80. PubMed ID: 17548592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role and plasticity of Th1 and Th17 responses in immunity to
    Ferraro A; Buonocore SM; Auquier P; Nicolas I; Wallemacq H; Boutriau D; van der Most RG
    Hum Vaccin Immunother; 2019; 15(12):2980-2992. PubMed ID: 31149870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells.
    Li T; Harada M; Tamada K; Abe K; Nomoto K
    Anticancer Res; 1997; 17(6D):4259-68. PubMed ID: 9494518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-derived suppressor cells attenuate TH1 development through IL-6 production to promote tumor progression.
    Tsukamoto H; Nishikata R; Senju S; Nishimura Y
    Cancer Immunol Res; 2013 Jul; 1(1):64-76. PubMed ID: 24777249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th17 and Th17-stimulated CD8⁺ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity.
    Ankathatti Munegowda M; Deng Y; Mulligan SJ; Xiang J
    Cancer Immunol Immunother; 2011 Oct; 60(10):1473-84. PubMed ID: 21660450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live Attenuated
    Banerjee A; Bhattacharya P; Dagur PK; Karmakar S; Ismail N; Joshi AB; Akue AD; KuKuruga M; McCoy JP; Dey R; Nakhasi HL
    J Immunol; 2018 Jan; 200(1):163-176. PubMed ID: 29187586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of antitumor immunity by cytotoxic T lymphocyte epitope peptide vaccination, CpG-oligodeoxynucleotide adjuvant, and CTLA-4 blockade.
    Davila E; Kennedy R; Celis E
    Cancer Res; 2003 Jun; 63(12):3281-8. PubMed ID: 12810660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An agonistic anti-Toll-like receptor 4 monoclonal antibody as an effective adjuvant for cancer immunotherapy.
    Tsukamoto H; Kubota K; Shichiku A; Maekawa M; Mano N; Yagita H; Ohta S; Tomioka Y
    Immunology; 2019 Oct; 158(2):136-149. PubMed ID: 31515801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2.
    Jackaman C; Bundell CS; Kinnear BF; Smith AM; Filion P; van Hagen D; Robinson BW; Nelson DJ
    J Immunol; 2003 Nov; 171(10):5051-63. PubMed ID: 14607902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma.
    Ma HL; Whitters MJ; Konz RF; Senices M; Young DA; Grusby MJ; Collins M; Dunussi-Joannopoulos K
    J Immunol; 2003 Jul; 171(2):608-15. PubMed ID: 12847225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant antigen P29 of
    Yang J; Zhao Y; Fu Y; Lv Y; Zhu Y; Zhu M; Zhao J; Wang Y; Wu C; Zhao W
    Front Immunol; 2023; 14():1243204. PubMed ID: 38187382
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor-infiltrating dendritic cell subsets of progressive or regressive tumors induce suppressive or protective immune responses.
    Liu Y; Bi X; Xu S; Xiang J
    Cancer Res; 2005 Jun; 65(11):4955-62. PubMed ID: 15930318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol Enhances Antiviral CD4
    Bagri P; Ghasemi R; McGrath JJC; Thayaparan D; Yu E; Brooks AG; Stämpfli MR; Kaushic C
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33028712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.